Nippon Life India Asset Management Limited runs 3 funds in the Sectoral Fund category, together managing roughly ₹23,372.186 Cr in assets. Across the 3 funds with a full 3-year track record, the average 3-year rolling CAGR is 18.1%. Nippon India Pharma Fund leads the group at 19.8% 3Y CAGR.
Figures here are computed directly from each fund's own NAV history and AUM - not survivor-biased averages from a fact sheet - so a fund that merged, closed, or changed category drops out of the comparison rather than skewing it. Click through to any fund above for its full return history, expense ratio, holdings, and risk profile.
Sectoral Fund is one of the standardized scheme categories SEBI mandated in its 2017 product categorization circular - every AMC runs Nippon Life India Asset Management Limited's funds in this category against the same investment-mandate rules every other AMC's funds in the same category follow, which is what makes a cross-AMC ranking like this one a like-for-like comparison rather than an apples-to-oranges one. A fund's rank here can change as new NAV data comes in or as other AMCs launch or close schemes in the same category, so treat this as a point-in-time snapshot rather than a fixed league table.
Looking for a different AMC's Sectoral funds, or want to compare Nippon Life India Asset Management Limited's funds against a different category? Use the breadcrumb above to jump back to all Sectoral fundsor the full mutual fund directory.